Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2

被引:40
|
作者
Vokurka, S. [1 ]
Steinerova, K. [1 ]
Karas, M. [1 ]
Koza, V. [1 ]
机构
[1] Univ Hosp Plzen Pilsen, Dept Haematooncol, Plzen 30460, Pilsen, Czech Republic
关键词
oral mucositis; melphalan; stem cell transplantation; toxicity; graft-versus-host disease; VERSUS-HOST-DISEASE; HIGH-DOSE MELPHALAN; MARROW-TRANSPLANTATION; CHEMOTHERAPY; FLUDARABINE; PREVENTION; RECIPIENTS; THERAPY; MYELOMA;
D O I
10.1038/bmt.2009.66
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The fludarabine ( FLU)/melphalan (MEL) conditioning regimen containing FLU and high-dose MEL was analyzed in comparison with the BU/CY2 regimen to characterize oral mucositis ( OM) and risk factors. OM incidence significantly varied between BU/CY2 and FLU/ MEL ( 100 vs 78%, P = 0.004), but the incidence of severe OM grades 3-4 WHO and kinetics of OM were fully comparable. Patients with OM persisting on day +21 had more acute GVHD (68 vs 32%, P = 0.005), which tended to occur earlier than among those without such prolonged OM. Multivariate analysis showed significant dependency of acute GVHD on severity and prolonged duration of OM and significant correlation between OM severity and its prolonged duration. Body surface area-based dosing in the FLU/ MEL regimen led to a wide range of MEL doses administered per kilogram body weight (2.5-5.2 mg/kg, median 3.5). In multivariate analysis, MEL dose per kilogram of body weight was found to be a significant predictor of OM incidence and severity. Female gender and lower body mass index were less important variables than the fact that the actual dose of MEL administered per kilogram of body weight was relatively high when the dosage was calculated on the basis of body surface area. Bone Marrow Transplantation ( 2009) 44, 601-605; doi: 10.1038/bmt.2009.66; published online 6 April 2009
引用
收藏
页码:601 / 605
页数:5
相关论文
共 50 条
  • [11] Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation
    Wysocka-Slowik, Aleksandra
    Gil, Lidia
    Slebioda, Zuzanna
    Kregielczak, Agnieszka
    Dorocka-Bobkowska, Barbara
    ANNALS OF HEMATOLOGY, 2021, 100 (08) : 2079 - 2086
  • [12] Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation
    Nygaard, M.
    Hovgaard, D.
    Schjodt, I. M.
    Andersen, N. S.
    Vindelov, L.
    Sengelov, H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 358 - 361
  • [13] Prevalence and risk factors of oral mucositis in paediatric patients undergoing haematopoietic stem cell transplantation
    Alhussain, Abdulmalik
    Alkhayal, Zikra
    Ayas, Mouhab
    Abed, Hassan
    ORAL DISEASES, 2022, 28 (03) : 657 - 669
  • [14] Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation
    Ohbayashi, Yumiko
    Imataki, Osamu
    Ohnishi, Hiroaki
    Iwasaki, Akinori
    Ogawa, Takaaki
    Inagaki, Noriko
    Shigeta, Hiroe
    Ohue, Yukiko
    Tasaka, Taizo
    Kitanaka, Akira
    Kubota, Yoshitsugu
    Tanaka, Terukazu
    Ishida, Toshihiko
    Miyake, Minoru
    ANNALS OF HEMATOLOGY, 2008, 87 (10) : 837 - 845
  • [15] Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation
    Yumiko Ohbayashi
    Osamu Imataki
    Hiroaki Ohnishi
    Akinori Iwasaki
    Takaaki Ogawa
    Noriko Inagaki
    Hiroe Shigeta
    Yukiko Ohue
    Taizo Tasaka
    Akira Kitanaka
    Yoshitsugu Kubota
    Terukazu Tanaka
    Toshihiko Ishida
    Minoru Miyake
    Annals of Hematology, 2008, 87 : 837 - 845
  • [16] Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
    Shigematsu, Akio
    Tanaka, Junji
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Kawase, Takakazu
    Ito, Yoichi M.
    Yamashita, Takuya
    Fukuda, Takahiro
    Kumano, Keiki
    Iwato, Koji
    Yoshiba, Fumiaki
    Kanamori, Heiwa
    Kobayashi, Naoki
    Fukuhara, Takashi
    Morishima, Yasuo
    Imamura, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (05) : 463 - 471
  • [17] A HIGHER INCIDENCE OF RELAPSE FOR ACUTE LYMPHOCYTIC LEUKEMIA TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONED WITH BU-CY2 REGIMEN
    朱康儿
    钟隽
    张涛
    曾慧兰
    Chinese Journal of Cancer Research, 2003, (03) : 60 - 63
  • [18] The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-L-PAM 200 mg/m2 autologous hematopoietic stem cell transplantation
    Vokurka, Samuel
    Bystricka, Eva
    Scudlova, Jana
    Mazur, Ewa
    Visokaiova, Maria
    Vasilieva, Elizabeth
    Brandejsova, Renata
    Chvojkova, Ivana
    Vrabcova, Martina
    Vitkova, Jitka
    Mjartanova, Dagmar
    Vodickova, Marcela
    Bockova, Jana
    Streinerova, Katerina
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2011, 15 (05) : 508 - 512
  • [19] The Effects of Two Kinds of Gargles on Oral Mucositis in Patients After Allogeneic Stem Cell Transplantation
    Hu, Wei
    Jiang, Hua
    Wang, Ting
    Guo, Xiu-Juan
    Zhang, Bei-Bei
    Song, Yan
    Shi, Ce
    Xu, Xiao-Dong
    Wang, Lin-Nan
    He, Xin-Xin
    Liu, Bo-ning
    Zhou, Jun-xiu
    Xue, Ze-yu
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (09) : 2027 - 2031
  • [20] Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation
    Verstraete, Emma
    Baumann, Cedric
    Rousseau, Helene
    Campidelli, Arnaud
    Rubio, Marie-Therese
    D'Aveni, Maud
    LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 283 - 286